Concepedia

HL McArthur

HM

Statistics

Publications

4

Citations

172

H-Index

4

Active since

2009

Affiliations

Westmead Hospital(Current)

National University of Singapore

Cedars-Sinai Medical Center

National Cancer Centre Singapore

Hokkaido University Hospital

HL McArthur is an author at Westmead Hospital specializing in oncology, medicine, and pharmacology.

Publications per year

2009–2024

4

Publications

4

VP7-2021: KEYNOTE-522: Phase III study of neoadjuvant pembrolizumab + chemotherapy vs. placebo + chemotherapy, followed by adjuvant pembrolizumab vs. placebo for early-stage TNBC

Peter Schmid, Javier Cortés, Rebecca Dent et al. · Annals of Oncology · 2021 · 133 citations · Full text

, , +16

Cardiac safety of adjuvant bevacizumab (B) plus dose-dense doxorubicin/cyclophosphamide (AC) followed by nanoparticle albumin-bound paclitaxel (nab-P) in patients with early stage breast cancer.

HL McArthur, Hope Rugo, Benjamin Nulsen et al. · Cancer Research · 2009 · 14 citations

, , +17

LBA4 Neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for high-risk early-stage TNBC: Overall survival results from the phase III KEYNOTE-522 study

P. Schmid, J. Cortés, R. Dent et al. · Annals of Oncology · 2024 · 14 citations · Full text

, , +16

Abstract P2-09-03: Updated efficacy of first or second-line pembrolizumab (pembro) plus capecitabine (cape) in metastatic triple negative breast cancer (mTNBC) and correlations with baseline lymphocyte and naïve CD4+ T-cell count

DB Page, Joanna Pucilowska, Laura Bennetts et al. · Cancer Research · 2019 · 11 citations

, , +17

1–4 of 4